{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:14Z","timestamp":1787030534683,"version":"build-2736575974"},"reference-count":36,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.3892\/etm.2015.2491","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T08:07:36Z","timestamp":1431418056000},"page":"175-180","source":"Crossref","is-referenced-by-count":31,"title":["Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia"],"prefix":"10.3892","volume":"10","author":[{"given":"JIANJUN","family":"WU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YU","family":"JIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAILONG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHIPING","family":"XIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINSONG","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUANYUN","family":"AO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHAOJUN","family":"DUAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"key":"key20180108124451_b1-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"key20180108124451_b2-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(05)71877-8","article-title":"WHO Child Health Epidemilogy Reference Group: WHO estimates of the causes of death in children","volume":"365","author":"Bryce","year":"2005","journal-title":"Lancet"},{"key":"key20180108124451_b3-etm-0-0-2491","first-page":"10401","article-title":"Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries","volume":"3","author":"Rudan","year":"2013","journal-title":"J Glob Health"},{"key":"key20180108124451_b4-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s12098-011-0412-2","article-title":"Acute community acquired pneumonia in emergency room","volume":"78","author":"Dekate","year":"2011","journal-title":"Indian J Pediatr"},{"key":"key20180108124451_b5-etm-0-0-2491","first-page":"25","article-title":"Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores","volume":"58","author":"Aydo\u011fdu","year":"2010","journal-title":"Tuberk Toraks"},{"key":"key20180108124451_b6-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America; American Thoracic Society: Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key20180108124451_b7-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"key20180108124451_b8-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/thx.2003.008110","article-title":"Validation of predictive rules and indices of severity for community acquired pneumonia","volume":"59","author":"Ewig","year":"2004","journal-title":"Thorax"},{"key":"key20180108124451_b9-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/thoraxjnl-2013-204247","article-title":"Pneumonia in low and middle income countries: progress and challenges","volume":"68","author":"Zar","year":"2013","journal-title":"Thorax"},{"key":"key20180108124451_b10-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(11)61714-5","article-title":"Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2\u201359 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial","volume":"379","author":"Soofi","year":"2012","journal-title":"Lancet"},{"key":"key20180108124451_b11-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00134-002-1209-6","article-title":"C-reactive protein: a valuable marker of sepsis","volume":"28","author":"P\u00f3voa","year":"2002","journal-title":"Intensive Care Med"},{"key":"key20180108124451_b12-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"327","DOI":"10.6061\/clinics\/2012(04)05","article-title":"The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection","volume":"67","author":"Paiva","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"key20180108124451_b13-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"243","DOI":"10.6061\/clinics\/2012(03)07","article-title":"Evaluation of serial C-reactive protein measurements after surgical treatment of pleural empyema","volume":"67","author":"Medeiros","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"key20180108124451_b14-etm-0-0-2491","first-page":"w13542","article-title":"Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia","volume":"142","author":"Suberviola","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"key20180108124451_b15-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"f2450","DOI":"10.1136\/bmj.f2450","article-title":"GRACE consortium: Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study","volume":"346","author":"van Vugt","year":"2013","journal-title":"BMJ"},{"key":"key20180108124451_b16-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00006454-200202000-00005","article-title":"Evaluation of children with recurrent pneumonia diagnosed by World Health Organization criteria","volume":"21","author":"Heffelfinger","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"key20180108124451_b17-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108124451_b18-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Infections Diseases Society of America: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key20180108124451_b19-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0924-8579(01)00405-8","article-title":"Worldwide guidelines for respiratory tract infections: community-acquired pneumonia","volume":"18","author":"Dalhoff","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"key20180108124451_b20-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/bmj.332.7549.1045","article-title":"Community acquired pneumonia in primary care","volume":"332","author":"Goossens","year":"2006","journal-title":"BMJ"},{"key":"key20180108124451_b21-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-7-10","article-title":"Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia","volume":"7","author":"Muller","year":"2007","journal-title":"BMC Infect Dis"},{"key":"key20180108124451_b22-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00134-011-2261-x","article-title":"Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis","volume":"37","author":"Chalmers","year":"2011","journal-title":"Intensive Care Med"},{"key":"key20180108124451_b23-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-142-3-200502010-00006","article-title":"Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients","volume":"142","author":"Carratala","year":"2005","journal-title":"Ann Intern Med"},{"key":"key20180108124451_b24-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/AAC.48.9.3323-3331.2004","article-title":"600 Study Group: Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000\/125 milligrams) versus those of amoxicillin-clavulanate (875\/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults","volume":"48","author":"File","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key20180108124451_b25-etm-0-0-2491","first-page":"169","article-title":"The effect of continuous renal replacement therapy on the outcome of severe pneumonia in patients receiving long-term immunosuppressants","volume":"36","author":"Zha","year":"2013","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"key20180108124451_b26-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1365-3156.2012.03035.x","article-title":"Procalcitonin and C-reactive protein as predictors of blood culture positivity among hospitalised children with severe pneumonia in Mozambique","volume":"17","author":"Diez-Padrisa","year":"2012","journal-title":"Trop Med Int Health"},{"key":"key20180108124451_b27-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-12-90","article-title":"CAPNETZ Study Group: Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study","volume":"13","author":"Kolditz","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key20180108124451_b28-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thx.2008.105312","article-title":"Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia","volume":"64","author":"Menendez","year":"2009","journal-title":"Thorax"},{"key":"key20180108124451_b29-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrc.2010.10.007","article-title":"Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia","volume":"26","author":"Lee","year":"2011","journal-title":"J Crit Care"},{"key":"key20180108124451_b30-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/INF.0b013e31826fd39b","article-title":"Viral and bacterial causes of severe acute respiratory illness among children aged less than 5 years in a high malaria prevalence area of western Kenya, 2007\u20132010","volume":"32","author":"Feikin","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key20180108124451_b31-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"e54026","DOI":"10.1371\/journal.pone.0054026","article-title":"High rates of pneumonia in children under two years of age in a South East Asian refugee population","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"key20180108124451_b32-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1471-2334-12-267","article-title":"Respiratory viruses from hospitalized children with severe pneumonia in the Philippines","volume":"12","author":"Suzuki","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key20180108124451_b33-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2334-9-157","article-title":"Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study","volume":"9","author":"Daubin","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key20180108124451_b34-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1471-2334-10-319","article-title":"Systemic bacteraemia in children presenting with clinical pneumonia and the impact of non-typhoid salmonella (NTS)","volume":"10","author":"Schwarz","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key20180108124451_b35-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00134-003-1761-8","article-title":"A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis","volume":"29","author":"Fischer","year":"2003","journal-title":"Intensive Care Med"},{"key":"key20180108124451_b36-etm-0-0-2491","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(02)09994-4","article-title":"Pakistan Muticentre Amoxycillin Short Course Therapy (MASCOT) Pneumonia Study Group: Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial","volume":"360","year":"2002","journal-title":"Lancet"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2491\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T16:59:18Z","timestamp":1515430758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,5,12]]},"published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3892\/etm.2015.2491"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2491","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}